-+ 0.00%
-+ 0.00%
-+ 0.00%

Eledon Pharma Q4 EPS $(0.10) Beats $(0.18) Estimate

Benzinga·03/19/2026 21:13:42
Listen to the news
Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.18) by 45.95 percent. This is a 84.38 percent increase over losses of $(0.64) per share from the same period last year.